Clinical Trials Browser

Completed × HER2-ve Metastatic Breast Cancer × Clear all

NCT03286842 2023-01-17

To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.

Phase 3 Completed

256 enrolled 17 charts

HER2-ve Metastatic Breast Cancer